HIGHLIGHTS
- who: September et al. from the University of Mississippi Medical Center, United States have published the paper: Drug repurposing candidates to treat core symptoms in autism spectrum disorder, in the Journal: (JOURNAL)
- what: The authors have identified existing drugs that could potentially be used for repurposing to address core symptoms in ASD.
SUMMARY
Autism spectrum disorder (ASD) is a heterogeneous group of neurodevelopmental phenotypes characterized by social and communication deficits along with restrictive behaviors (Lord et_al, 2018), most often accompanied with psychiatric comorbidities such as sleep problems, anxiety, depression, ADHD, or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.